Lifeway Foods, Inc. — FY 2014 Form 10-K
Reporting period: Year ended December 31, 2014; filed August 13, 2015. This is an annual report, not a standalone fourth-quarter report, and the provided filing text does not give clear Q4-only financial results. Lifeway manufactures and sells cultured dairy products, primarily kefir, in the United States and through limited international distribution.
Financial performance
| Metric | FY 2014 | FY 2013 | Change |
|---|---|---|---|
| Net sales | $119.0 million | $97.5 million | +22% |
| Gross profit | $28.9 million | $27.6 million | +4% |
| Income from operations | $4.2 million | $8.0 million | -47% |
| Net income | $2.0 million | $5.0 million | -61% |
| Diluted EPS | $0.12 | $0.31 | Down $0.19 |
| Cash from operating activities | $5.1 million | $5.8 million | Down $0.7 million |
| Cash and cash equivalents at year-end | $3.3 million | $3.3 million | Nearly unchanged |
- Gross margin was approximately 24.3%, down from 28.3%; operating margin was 3.6%, down from 8.2%; net margin was 1.6%, down from 5.1%.
- Sales growth reflected higher volume and pricing: management attributed about $18.1 million of gross-sales growth to volume and $3.2 million to price increases. Drinkable kefir, excluding ProBugs, generated $110.3 million of gross sales; ProBugs contributed $7.9 million.
- Costs rose faster than sales. Total cost of goods sold increased 29%, including higher purchases, freight, labor and overhead, and depreciation. Selling and general and administrative expenses also increased, including higher advertising, staffing and professional fees.
- The income-tax provision was $2.24 million, with a 53.4% effective rate versus 36.6% in 2013. The filing cites prior-year tax-position additions and other tax adjustments among the reconciling items.
Financial position and liquidity
- At December 31, 2014, total assets were $63.4 million, current assets $24.2 million, current liabilities $8.5 million, and stockholders’ equity $44.7 million. The current ratio was approximately 2.8.
- Total notes payable were $9.0 million, including $0.9 million due within one year; the bulk was variable-rate Private Bank debt. The company reported no revolving-credit borrowings and approximately $5 million of available capacity. The line was subsequently extended to July 2016.
- Cash used in investing was $4.3 million, principally reflecting $3.7 million of property and equipment purchases. Cash used in financing was $0.9 million, primarily debt repayment; cash declined by $46,000 over the year.
- Management said foreseeable liquidity needs could be funded internally and that it continued to explore acquisitions. No off-balance-sheet financing arrangements were reported.
Material changes, outlook and risks
- Despite 22% net-sales growth, operating income and net income fell substantially as production, freight, personnel, depreciation and operating expenses increased. Management attributed several cost increases to the Wisconsin facility acquired in 2013.
- The Wisconsin facility began production and packaging in June 2015, after the reporting year. Management expected in-house raw-milk processing to reduce the cost of its major ingredient by approximately 5% compared with buying processed milk; the filing does not establish realized savings.
- The filing gives no quantified revenue or earnings guidance. Management described continued product development, expansion of production and distribution, and potential acquisitions, while cautioning that growth plans and new products may not succeed.
- Two customers accounted for approximately 28% of gross sales and 23% of year-end receivables; one distributor alone represented about 21% of sales. Customer arrangements were generally not supported by written long-term contracts.
- Variable-rate debt exposes the company to interest-rate risk: management estimated a one-percentage-point rate increase would add about $90,000 in annual interest expense. Debt agreements include financial covenants and operating restrictions; the company reported covenant compliance at year-end.
- Management recorded prior-period corrections during 2014 that reduced pretax income by approximately $600,000 and net income by approximately $400,000, which it judged immaterial to previously filed statements. The filing also reports an approximately $470,000 depreciation adjustment related to Starfruit leasehold improvements.
- The independent auditor gave an unqualified opinion on the 2014 financial statements but an adverse opinion on internal control over financial reporting. Material weaknesses involved entity-level oversight, financial-statement preparation and reconciliations, corporate-card expenses, fixed assets, and income taxes. The company also said disclosure controls were ineffective and the weaknesses contributed to delayed SEC filings.
- Nasdaq notified Lifeway that it was out of compliance with periodic filing requirements after the 2014 Form 10-K and first-quarter 2015 Form 10-Q were late. The company said it was working to regain compliance. Management reported ordinary-course litigation but no material pending legal proceeding; it also disclosed that employees at the Wisconsin facility had begun seeking a union vote.
Investor verification priorities
- Confirm remediation and independent testing of the disclosed internal-control weaknesses, and whether later filings were timely and controls effective.
- Track operating and gross margins, especially whether Wisconsin production delivers the expected cost savings and whether freight and labor costs moderate.
- Review customer concentration, retention and receivable collection, including exposure to the largest distributor.
- Verify liquidity, debt-covenant compliance, variable-rate exposure and the terms and availability of the extended revolving facility.
- Reconcile the 2014 tax rate and prior-period adjustments, and monitor any further corrections, restatements or audit findings.
- Assess the Wisconsin facility’s utilization, required capital spending, and the operational and financial effects of the unionization process.